Determination of the blood concentrations of cyanate after intravenous administration to patients with sickle-cell disease.
D000755:Anemia, Sickle Cell / Q000097:blood* / Q000188:drug therapy / Q000378:metabolism; D002219:Carbamates / Q000032:analysis; D002250:Carbon Radioisotopes; D055598:Chemical Phenomena; D002621:Chemistry; D002845:Chromatography; D003485:Cyanates / Q000008:administration & dosage / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use; D003545:Cysteine / Q000032:analysis; D006207:Half-Life; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous; D008722:Methods; D013447:Sulfites
D002219:Carbamates; D002250:Carbon Radioisotopes; D003485:Cyanates; D013447:Sulfites; D003545:Cysteine